Lisata Therapeutics

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-45
-46
-47
EBITDA
-5,478
-6,555
-5,978
EBIT
-5,523
-6,601
-6,025
Net Income
-4,930
-5,044
-5,401
-5,365
Net Change In Cash
0
0
0
0
Free Cash Flow
-2,518
-5,283
-7,027
-4,069
Cash
19,509
28,293
21,805
22,593
Basic Shares
8,321
8,308
8,294
8,140

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$121,372
$0
$0
Gross Profit
-189
63,771
-55
-63
EBITDA
-25,519
-115,202
-28,995
-19,082
EBIT
-25,708
-115,271
-29,050
-19,145
Net Income
-20,840
-54,225
-27,466
-8,141
Net Change In Cash
0
121,372
0
0
Free Cash Flow
-20,032
-21,455
-22,305
-8,843
Cash
22,593
32,154
24,647
16,512
Basic Shares
8,073
5,180
3,687
1,029

Earnings Calls

Quarter EPS
2024-09-30
-$0.59
2024-06-30
-$0.61
2024-03-31
-$0.65
2023-12-31
-$0.66